ASTRAZENECA PLC (AZN)
Clinical trial NCT03691714 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. enrollment: 36 → 35 participants
Clinical trial NCT03691714 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. enrollment: 36 → 35 participants
Clinical trial NCT04557462 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 540 → 448 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT03600350: primary completion date: 2022-12-05 → 2022-11-07.
Clinical trial NCT05469360 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2028-01-02 → 2027-09-24 3. primary completion date: 2026-09-11 → 2026-07-30 4. enrollment: 36 → 38 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05330520: status: RECRUITING → ACTIVE_NOT_RECRUITING.
Clinical trial NCT04753879: status: RECRUITING → ACTIVE_NOT_RECRUITING.
Clinical trial NCT06923202 updates: 1. start date: 2026-01-30 → 2026-02-10 2. completion date: 2026-11-26 → 2027-02-10 3. primary completion date: 2026-11-26 → 2027-02-10
Clinical trial NCT07500298 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-09-03 → 2026-05-20
Clinical trial NCT06543914 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 1000 → 1314 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05783622 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-10-01 → 2026-10-31 3. primary completion date: 2026-01-01 → 2026-07-31